Monoclonal gammopathy-associated peripheral neuropathies: Uncovering pearls and challenges.
Trajano Aguiar Pires GonçalvesCamila Derminio DonadelRodrigo Siqueira Soares FrezattiPedro Manoel Marques GaribaldiRodrigo do Tocantins CaladoOswaldo Wiliam Marques JuniorPedro José TomaselliPublished in: Journal of the peripheral nervous system : JPNS (2024)
Monoclonal gammopathy-related peripheral neuropathies encompass a spectrum of clinical presentations in which the monoclonal protein directly damages the tissues, including the peripheral nervous system. Given the prevalence of both peripheral neuropathy and monoclonal gammopathy in the general population, these conditions may overlap in clinical practice, posing a challenge for clinicians in determining causality. Therefore, a comprehensive understanding of primary clinical syndromes and their neurophysiological patterns is of great importance for accurate differential diagnoses and effective treatment strategies. In this article, we examine the main forms of monoclonal gammopathies that affect the peripheral nerve. We explore the clinical and electrophysiological aspects and their correlation with each syndrome's corresponding monoclonal protein type. This knowledge is essential for healthcare professionals to diagnose better and manage patients presenting with monoclonal gammopathy-related peripheral nervous system involvement.